These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 9453517)

  • 1. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.
    Nagaya N; Nishikimi T; Goto Y; Miyao Y; Kobayashi Y; Morii I; Daikoku S; Matsumoto T; Miyazaki S; Matsuoka H; Takishita S; Kangawa K; Matsuo H; Nonogi H
    Am Heart J; 1998 Jan; 135(1):21-8. PubMed ID: 9453517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma natriuretic peptides as indicators of left ventricular remodeling after myocardial infarction.
    Yoshitomi Y; Nishikimi T; Kojima S; Kuramochi M; Takishita S; Kangawa K; Matsuo H
    Int J Cardiol; 1998 Apr; 64(2):153-60. PubMed ID: 9688434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW
    Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained elevation of plasma brain natriuretic peptide levels associated with progressive ventricular remodelling after acute myocardial infarction.
    Nagaya N; Goto Y; Nishikimi T; Uematsu M; Miyao Y; Kobayashi Y; Miyazaki S; Hamada S; Kuribayashi S; Takamiya M; Matsuo H; Kangawa K; Nonogi H
    Clin Sci (Lond); 1999 Feb; 96(2):129-36. PubMed ID: 9918892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
    Yamamoto K; Burnett JC; Jougasaki M; Nishimura RA; Bailey KR; Saito Y; Nakao K; Redfield MM
    Hypertension; 1996 Dec; 28(6):988-94. PubMed ID: 8952587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.
    Motwani JG; McAlpine H; Kennedy N; Struthers AD
    Lancet; 1993 May; 341(8853):1109-13. PubMed ID: 8097802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure.
    Haug C; Metzele A; Kochs M; Hombach V; Grünert A
    Clin Cardiol; 1993 Jul; 16(7):553-7. PubMed ID: 8348764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmented secretion of atrial and brain natriuretic peptides during dynamic exercise in patients with old myocardial infarction.
    Marumoto K; Hamada M; Aburaya M; Hiwada K
    Jpn Circ J; 1995 Nov; 59(11):715-24. PubMed ID: 8747761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of carboxyterminal propeptide of type I procollagen and left ventricular remodeling after myocardial infarction.
    Takino T; Nakamura M; Hiramori K
    Cardiology; 1999; 91(2):81-6. PubMed ID: 10449877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
    Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
    Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
    Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
    Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.
    Nishikimi T; Yoshihara F; Morimoto A; Ishikawa K; Ishimitsu T; Saito Y; Kangawa K; Matsuo H; Omae T; Matsuoka H
    Hypertension; 1996 Jul; 28(1):22-30. PubMed ID: 8675258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
    Cataliotti A; Malatino LS; Jougasaki M; Zoccali C; Castellino P; Giacone G; Bellanuova I; Tripepi R; Seminara G; Parlongo S; Stancanelli B; Bonanno G; Fatuzzo P; Rapisarda F; Belluardo P; Signorelli SS; Heublein DM; Lainchbury JG; Leskinen HK; Bailey KR; Redfield MM; Burnett JC
    Mayo Clin Proc; 2001 Nov; 76(11):1111-9. PubMed ID: 11702899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac natriuretic peptides after myocardial infarction: relationship with infarct size, left ventricular function and remodelling assessed by 99mTc-sestamibi gated-single photon emission tomography.
    Ceriani L; Giovanella L
    Clin Chem Lab Med; 2007; 45(2):226-31. PubMed ID: 17311513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma C-reactive protein predicts left ventricular remodeling and function after a first acute anterior wall myocardial infarction treated with coronary angioplasty: comparison with brain natriuretic peptide.
    Morishima I; Sone T; Tsuboi H; Kondo J; Mukawa H; Kamiya H; Hieda N; Okumura K
    Clin Cardiol; 2002 Mar; 25(3):112-6. PubMed ID: 11890369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.
    Morita E; Yasue H; Yoshimura M; Ogawa H; Jougasaki M; Matsumura T; Mukoyama M; Nakao K
    Circulation; 1993 Jul; 88(1):82-91. PubMed ID: 8319360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction.
    Arakawa N; Nakamura M; Aoki H; Hiramori K
    J Am Coll Cardiol; 1996 Jun; 27(7):1656-61. PubMed ID: 8636550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.